The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
暂无分享,去创建一个
[1] Yolanda F. Darlington,et al. Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair* , 2010, The Journal of Biological Chemistry.
[2] Xiongbin Lu,et al. Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response. , 2009, Cancer research.
[3] P. Plevani,et al. Checkpoint mechanisms at the intersection between DNA damage and repair. , 2009, DNA repair.
[4] W. Chazin,et al. Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A* , 2009, The Journal of Biological Chemistry.
[5] Marketa Zvelebil,et al. PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas , 2009, Clinical Cancer Research.
[6] T. Nouspikel. Nucleotide excision repair : variations on versatility , 2009 .
[7] R. Rouget,et al. ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells , 2008, Proceedings of the National Academy of Sciences.
[8] K. Cimprich,et al. ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.
[9] K. Jan,et al. Direct involvement of the tumor suppressor p53 in nucleotide excision repair. , 2008, DNA repair.
[10] Jiri Bartek,et al. An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.
[11] Yolanda F. Darlington,et al. The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways , 2008, Cancer and Metastasis Reviews.
[12] Xiongbin Lu,et al. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.
[13] B. A. Ballif,et al. ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.
[14] Xinbin Chen,et al. p53 modulation of the DNA damage response , 2007, Journal of cellular biochemistry.
[15] Marie-Claude Marsolier-Kergoat,et al. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase , 2007, Oncogene.
[16] Y. Zou,et al. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation , 2007, Oncogene.
[17] E. Appella,et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.
[18] L. Donehower,et al. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice , 2006, Molecular carcinogenesis.
[19] N. Onishi,et al. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase , 2006, Cell Death and Differentiation.
[20] Y. Zou,et al. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. , 2006, Cancer research.
[21] Ludovic C. Gillet,et al. Molecular mechanisms of mammalian global genome nucleotide excision repair. , 2006, Chemical reviews.
[22] D. Hallahan,et al. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. , 2006, Cancer research.
[23] Chen-Yang Shen,et al. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. , 2006, Cancer research.
[24] Päivikki Kauraniemi,et al. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours , 2006, Breast Cancer Research and Treatment.
[25] L. Donehower,et al. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.
[26] L. Donehower,et al. Reversal of the ATM/ATR-Mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D , 2005, Cell cycle.
[27] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[28] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[29] S. Durell,et al. Substrate Specificity of the Human Protein Phosphatase 2Cδ, Wip1† , 2005 .
[30] F. Gruijl,et al. Powerful Skin Cancer Protection by a CPD-Photolyase Transgene , 2005, Current Biology.
[31] J. Latimer,et al. Analysis of DNA repair using transfection-based host cell reactivation. , 2005, Methods in molecular biology.
[32] S. Durell,et al. Substrate specificity of the human protein phosphatase 2Cdelta, Wip1. , 2005, Biochemistry.
[33] W. Vermeulen,et al. Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity , 2004, The EMBO journal.
[34] L. Donehower,et al. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. , 2004, Molecular cell.
[35] J. Inazawa,et al. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Akira Nakagawara,et al. PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.
[37] Y. Shiloh. ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.
[38] J. Ford,et al. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Nakajima,et al. Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice , 2002, The EMBO journal.
[40] Jeffrey R. Marks,et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.
[41] Albert J. Fornace,et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.
[42] M. Christmann,et al. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity. , 2002, Nucleic acids research.
[43] Y. Seo,et al. p53 regulation of DNA excision repair pathways. , 2002, Mutagenesis.
[44] Lawrence A. Donehower,et al. Mice Deficient for the Wild-Type p53-Induced Phosphatase Gene (Wip1) Exhibit Defects in Reproductive Organs, Immune Function, and Cell Cycle Control , 2002, Molecular and Cellular Biology.
[45] E. Friedberg. How nucleotide excision repair protects against cancer , 2001, Nature Reviews Cancer.
[46] J. Hoeijmakers. Genome maintenance mechanisms for preventing cancer , 2001, Nature.
[47] Masaaki Adachi,et al. p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.
[48] Y. Shiloh,et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products , 2000, Nature.
[49] P. Hanawalt,et al. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Fiscella,et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Wood,et al. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts. , 1996, Nucleic acids research.